![Arno Hartmann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Arno Hartmann
Directeur/Bestuurslid bij
BioVascular, Inc.
Profiel
Arno Hartmann is currently a Director at Tioga Pharmaceuticals, Inc. and BioVascular, Inc. He was formerly a Director at Vaximm AG.
He received his undergraduate and doctorate degrees from the University of Giessen in 1987.
Actieve functies van Arno Hartmann
| Bedrijven | Functie | Begin |
|---|---|---|
BioVascular, Inc.
 BioVascular, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and devices for control of intimal hyperplasia associated with vascular procedures | Directeur/Bestuurslid | - |
Tioga Pharmaceuticals, Inc.
 Tioga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of gastrointestinal diseases | Directeur/Bestuurslid | - |
Eerdere bekende functies van Arno Hartmann
| Bedrijven | Functie | Einde |
|---|---|---|
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Develops immunotherapies for cancer treatment | Directeur/Bestuurslid | - |
Opleiding van Arno Hartmann
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
20
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Tioga Pharmaceuticals, Inc.
Tioga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of gastrointestinal diseases | Health Technology |
University of Giessen
 University of Giessen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioVascular, Inc.
BioVascular, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and devices for control of intimal hyperplasia associated with vascular procedures | Health Technology |
Vaximm AG
Vaximm AG Miscellaneous Commercial ServicesCommercial Services Develops immunotherapies for cancer treatment | Commercial Services |
